Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George T. Budd, MD
The Cleveland Clinic
Study Chair - George W. Sledge, MD
Indiana University
Study Chair - James N. Ingle, MD
Mayo Clinic
Study Chair - Manuela Rabaglio, MD
Insel Gruppe AG, University Hospital Bern
Principal Investigator - Matthew J. Ellis, MD, PhD, FRCP
Washington University Siteman Cancer Center
Study Chair - Paul E. Goss, MD, PhD
Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
39 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Lethbridge Cancer Centre
Lethbridge, Alberta, Canada
- Bcca - Cancer Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Penticton Regional Hospital
Penticton, British Columbia, Canada
- Bcca - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- Bcca - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Bcca - Vancouver Island Cancer Centre
Victoria, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- the Vitalite Health Network - Dr. Leon Richard
Moncton, New Brunswick, Canada
- Atlantic Health Sciences Corporation
Saint John, New Brunswick, Canada
- Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Quinte Healthcare Corporation
Belleville, Ontario, Canada
- Cambridge Memorial Hospital
Cambridge, Ontario, Canada
- Regional Cancer Program of the Hopital Regional
Greater Sudbury, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
- Grand River Regional Cancer Centre
Kitchener, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Credit Valley Hospital
Mississauga, Ontario, Canada
- Stronach Regional Health Centre at Southlake
Newmarket, Ontario, Canada
- Lakeridge Health Oshawa
Oshawa, Ontario, Canada
- Algoma District Cancer Program
Sault Ste. Marie, Ontario, Canada
- Niagara Health System
St. Catharines, Ontario, Canada
- Thunder Bay Regional Health Science Centre
Thunder Bay, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- Odette Cancer Centre
Toronto, Ontario, Canada
- St. Michael'S Hospital
Toronto, Ontario, Canada
- Trillium Health Centre - West Toronto
Toronto, Ontario, Canada
- Univ. Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Pei Cancer Treatment Centre,queen Elizabeth Hospital
Charlottetown, Prince Edward Island, Canada
- Centre de Sante Et de Services Sociaux de Gatineau
Gatineau, Quebec, Canada
- Hopital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Cha-Hopital Du St-Sacrement
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jun 2003
- Primary completion
- 7 Nov 2010
- Completion
- 6 Jan 2012
- Last update posted
- 25 Aug 2023
- Registered enrollment
- 7,576
- Registry id
- NCT00066573
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.